NeuroSigma, Inc., a Los Angeles-based bioelectronics company focused on commercializing Trigeminal Nerve Stimulation (TNS) technology for treating neurological and neuropsychiatric disorders today announced that its Monarch® eTNS® System (Monarch) received FDA clearance as a non-drug treatment for attention deficit hyperactivity disorder (ADHD).
Waters Corporation today announced the availability of a range of new TA Instruments™ innovations headlined by the Discovery™ Thermomechanical Analyzer (TMA) 450, a Rheo-Raman™ capability for the Discovery Hybrid Rheometer, and a High Sensitivity Pressure Cell for the ARES-G2 Rheometer at the 2019 Pittcon Conference and Expo.
HealthNet Global (HNG), a part of the Apollo Hospitals Group, India and Zebra Medical Vision (Zebra-Med), one of the global leaders in AI Imaging software, Israel announced today a new collaboration that will focus on validating and deploying AI based tools at scale across India.
Medacta® International, the international orthopaedics company specializing in the design and production of innovative orthopaedic products, and Geisinger, one of the nation’s most innovative health systems..
UK International orthopedic company Corin Group, backed by the Permira funds, has acquired the US-based OMNI Orthopedics ("OMNI"), a pioneer in robotic-assisted total knee replacement.
Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, today announced 510(k) clearance for its uncemented Press Fit humeral implant.
Vcpi, a nationwide provider of outsourced IT services and Pioneer Solution, a US manufacturer of point of care (POC) tablets and mobile workstations have announced a strategic marketing collaboration for the long-term and post-acute care (LTPAC) industry.
At the Summit for Clinical Ops Executives (SCOPE), Florence and SignalPath announced a strategic partnership to optimize clinical research operations through the integration of their industry leading offerings.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Miami Cancer Institute, part of Baptist Health South Florida, today announced the implementation of Philips' IntelliSpace Precision Medicine Genomics in its new state-of-the-art genomics laboratory.
Resideo Technologies, Inc. (NYSE: REZI) announced today a refresh of the company's LifeStream telehealth software platform to manage remote patient care.